Aligos Therapeutics Inc. (ALGS)
23.69
-0.25 (-1.06%)
At close: Jan 30, 2025, 3:59 PM
23.80
0.44%
After-hours Jan 30, 2025, 05:12 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| PE Ratio | -4.71 | -10.59 | -92.16 | -217.66 | -155.79 | -564.11 |
| PS Ratio | 26.59 | 73.13 | 2.71K | n/a | n/a | n/a |
| PB Ratio | 4.48 | 9.79 | 64.02 | 107.37 | -125.47 | -571.7 |
| P/FCF Ratio | -5.23 | -12.66 | -101.47 | -309.53 | -164.31 | -917.66 |
| P/OCF Ratio | -5.23 | -12.81 | -102.26 | -318.13 | -174.1 | -1.30K |
| OCF/S Ratio | -5.09 | -5.71 | -26.53 | n/a | n/a | n/a |
| Debt / Equity Ratio | 0.12 | 0.12 | 0.08 | 0.06 | -0.22 | -1.01 |
| Quick Ratio | 5.90 | 4.03 | 5.25 | 8.26 | 8.70 | 12.33 |
| Current Ratio | 5.90 | 4.03 | 5.25 | 8.26 | 8.70 | 12.33 |
| Asset Turnover | 0.10 | 0.09 | 0.02 | n/a | n/a | n/a |
| Interest Coverage | n/a | -59.5 | -972.13 | -9.28 | n/a | n/a |
| Return on Equity (ROE) | -0.95 | -0.92 | -0.69 | -0.49 | 0.81 | 1.01 |
| Return on Assets (ROA) | -0.58 | -0.65 | -0.55 | -0.41 | -0.36 | -0.13 |
| Return on Capital (ROIC) | -0.69 | -0.86 | -0.65 | -0.42 | -0.41 | -0.14 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 80.24% | 73.57% | -2.29K% | n/a | n/a | n/a |
| Net Profit Margin | -564.61% | -690.63% | -2.94K% | n/a | n/a | n/a |
| Pretax Profit Margin | -559.5% | -689.87% | -2.94K% | n/a | n/a | n/a |
| Operating Profit Margin | -567.5% | -701.66% | -2.94K% | n/a | n/a | n/a |
| FCF Margin | -508.83% | -577.64% | -2.67K% | n/a | n/a | n/a |
| EBITDA Margin | -547.74% | -675.24% | -2.86K% | n/a | n/a | n/a |